Well-Being Therapy and Lifestyle Intervention in Type 2 Diabetes: A Pilot Randomized Controlled Trial. Issue 9 (2nd November 2022)

• Record Type: Journal Article
• Authors: Benasi, Giada; Gostoli, Sara; Zhu, Boheng; Offidani, Emanuela; Artin, Michael G.; Gagliardi, Lorenza; Rignanese, Giovanni; Sassi, Graziella; Fava, Giovanni A.; Rafanelli, Chiara
• Is Part Of: Psychosomatic medicine. Volume 84:Issue 9(2022)
• Page Start: 1041
• Page End: 1049
• Publication Date: 2022-11-02
• Subjects: type 2 diabetes -- obesity -- well-being therapy -- euthymia -- lifestyle -- AMD = adjusted mean difference -- WBT = well-being therapy; Medicine, Psychosomatic -- Periodicals; 616.0805
• DOI: 10.1097/PSY.0000000000001115
• Languages: English
• ISSNs: 0033-3174

Abstract

ABSTRACT: Objective: This pilot randomized controlled trial evaluates the preliminary efficacy of a 4-month well-being therapy (WBT) and lifestyle intervention among adults with type 2 diabetes and overweight/obesity. Methods: Fifty-eight patients were recruited from two outpatient clinics and randomized to receive the WBT-lifestyle intervention or the lifestyle intervention alone. Data were collected at baseline (T0), immediate postintervention (T1), 6-month follow-up (T2), and 12-month follow-up (T3). Primary efficacy outcomes included changes in weight, psychological distress, and well-being, whereas secondary efficacy outcomes included changes in lifestyle and physiological parameters. Results: Compared with the lifestyle-alone intervention, the WBT-lifestyle intervention showed greater improvements in depression ( p = .009, d = −0.6), hostility ( p = .018, d = −0.6), and personal growth ( p = .026, d = 0.5) at T1, in self-reported physical activity at T2 ( p = .013, d = 0.7) and T3 ( p = .040, d = 0.5), and in triglycerides ( p = .019, d = −1.12) at T3. There were no differences between treatment groups in weight and other physiological parameters. Conclusions: These findings suggest that WBT may be a valuable addition to lifestyle interventions for improving short-term psychological outcomes and promoting long-term healthy changes in physical activity, with a potential impact on physiological outcomes. Trial Registration: ClinicalTrials.gov identifier: NCT03609463 .